Income Statement Orient EuroPharma Co., Ltd.

Equities

4120

TW0004120001

Food Processing

End-of-day quote Taipei Exchange Other stock markets 09/03/2026			5-day change	1st Jan Change
43.35 ^TWD	-1.37%		-1.48%	-3.24%

01-07	Rakuten Medical, Inc. announced that it has received $100 million in funding from a group of investors	CI
12-22	Orient Europharma Co., Ltd. Announces Change of Chief Audit Officer	CI

88e958.5fa7wPP67L8OrhzunK1WryZaZu6zjquFRXSS5t5wR88.l4z8qMag3s5h9CiP7Mwy-U48Xrn22NvGKh__hLNJfoi9lfaSkYu1-G-WJA

Published financial data: ORIENT EUROPHARMA CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	5.38B	4.77B	4.73B	4.59B	4.39B
Total Revenues	5.38B	4.77B	4.73B	4.59B	4.39B
Cost of Goods Sold, Total	2.96B	2.62B	2.7B	2.44B	2.33B
Gross Profit	2.42B	2.15B	2.03B	2.15B	2.07B
Selling General & Admin Expenses, Total	743M	1.92B	1.92B	1.87B	1.81B
Provision for Bad Debts	-356K	-	-396K	1.53M	20.04M
R&D Expenses	367M	331M	260M	207M	242M
Amortization of Goodwill and Intangible Assets - (IS)	1.2B	-	-	-	-
Other Operating Expenses, Total	2.3B	2.25B	2.18B	2.08B	2.07B
Operating Income	118M	-98.15M	-150M	70.61M	-6.72M
Interest Expense, Total	-30.23M	-38.04M	-69.53M	-106M	-107M
Interest And Investment Income	16.04M	11.85M	20.96M	50.86M	48.87M
Net Interest Expenses	-14.19M	-26.18M	-48.57M	-55.24M	-58.36M
Income (Loss) On Equity Invest.	-16.88M	-19.14M	-30.14M	-18.26M	-27.29M
Currency Exchange Gains (Loss)	126M	11.6M	-178M	-25.59M	-112M
Other Non Operating Income (Expenses)	36.45M	41.69M	40.54M	50.08M	71.11M
EBT, Excl. Unusual Items	249M	-90.18M	-365M	21.6M	-133M
Gain (Loss) On Sale Of Investments	-	-	-	-	6.15M
Gain (Loss) On Sale Of Assets	1.07M	182M	72.35M	234M	-4.83M
Asset Writedown	-	-10M	-35.3M	-	-
Other Unusual Items	99K	2.56M	45K	158K	1.8M
EBT, Incl. Unusual Items	250M	84.77M	-328M	256M	-130M
Income Tax Expense	143M	10.47M	-32.77M	86.97M	101M
Earnings From Continuing Operations	107M	74.3M	-295M	169M	-231M
Net Income to Company	107M	74.3M	-295M	169M	-231M
Minority Interest	92.42M	45.88M	-15.44M	-25.34M	-52.74M
Net Income - (IS)	199M	120M	-311M	144M	-284M
Net Income to Common Incl Extra Items	199M	120M	-311M	144M	-284M
Net Income to Common Excl. Extra Items	199M	120M	-311M	144M	-284M
Per Share Items
Net EPS - Basic	2.3	1.39	-3.58	1.66	-3.27
Basic EPS - Continuing Operations	2.3	1.39	-3.58	1.66	-3.27
Basic Weighted Average Shares Outstanding	86.75M	86.75M	86.75M	86.75M	86.75M
Net EPS - Diluted	2.29	1.38	-3.58	1.66	-3.27
Diluted EPS - Continuing Operations	2.29	1.38	-3.58	1.66	-3.27
Diluted Weighted Average Shares Outstanding	87.14M	86.96M	86.75M	86.95M	86.75M
Normalized Basic EPS	2.86	-0.12	-2.81	-0.14	-1.57
Normalized Diluted EPS	2.84	-0.12	-2.81	-0.14	-1.57
Dividend Per Share	1.5	0.85	-	1	1
Payout Ratio	78.35	108.28	-23.72	-	-30.55
Supplemental Items
EBITDA	279M	57.87M	28.61M	236M	153M
EBITA	140M	-75.48M	-143M	74.72M	-3.53M
EBIT	118M	-98.15M	-150M	70.61M	-6.72M
EBITDAR	293M	77.45M	55.03M	253M	175M
Effective Tax Rate - (Ratio)	57.23	12.35	9.99	33.94	-77.86
Total Current Taxes	72.63M	44.79M	38.81M	199M	61.01M
Total Deferred Taxes	70.38M	-34.32M	-71.58M	-112M	40.2M
Normalized Net Income	248M	-10.48M	-244M	-11.85M	-136M
Interest on Long-Term Debt	4.38M	4.1M	5.19M	7.73M	7.06M
Non-Cash Pension Expense	320K	254K	2M	876K	532K
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	1.21B	1.2B	1.12B	1.03B
General and Administrative Expenses	743M	705M	724M	745M	776M
Research And Development Expense From Footnotes	367M	331M	260M	207M	242M
Net Rental Expense, Total	14.4M	19.58M	26.42M	17.6M	21.42M
Imputed Operating Lease Interest Expense	1.52M	1.8M	3.18M	3.03M	4.05M
Imputed Operating Lease Depreciation	12.87M	17.78M	23.24M	14.57M	17.37M
Stock-Based Comp., Other (Total)	1.98M	136K	-	-	-
Total Stock-Based Compensation	1.98M	136K	-	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	2.12B	1.96B	1.8B	1.74B	1.44B
Short Term Investments	208M	80.8M	70.8M	366M	174M
Total Cash And Short Term Investments	2.33B	2.04B	1.87B	2.1B	1.61B
Accounts Receivable, Total	524M	580M	730M	783M	847M
Other Receivables	18.16M	33.53M	27.66M	26.94M	21.44M
Total Receivables	542M	614M	758M	810M	869M
Inventory	1.35B	1.08B	1.3B	1.15B	1.06B
Prepaid Expenses	87.96M	136M	162M	118M	137M
Other Current Assets, Total	8.05M	53.63M	88.62M	50.83M	296M
Total Current Assets	4.32B	3.93B	4.19B	4.23B	3.98B
Gross Property Plant And Equipment	3.57B	4.97B	4.91B	5.03B	4.97B
Accumulated Depreciation	-680M	-791M	-893M	-1.04B	-1.12B
Net Property Plant And Equipment	2.89B	4.18B	4.02B	3.99B	3.85B
Long-term Investments	191M	417M	534M	1.06B	2.3B
Other Intangibles, Total	104M	78.16M	43.01M	42.69M	43.76M
Deferred Tax Assets Long-Term	522M	632M	588M	677M	623M
Other Long-Term Assets, Total	131M	171M	1.06B	814M	780M
Total Assets	8.16B	9.4B	10.43B	10.81B	11.57B
Liabilities
Accounts Payable, Total	319M	160M	552M	348M	176M
Accrued Expenses, Total	444M	450M	353M	280M	297M
Short-term Borrowings	1.22B	2.05B	2.19B	2.32B	2.11B
Current Portion of Long-Term Debt	159M	247M	350M	272M	380M
Current Portion of Leases	32.41M	25.78M	44.06M	41.95M	38.79M
Current Income Taxes Payable	13.76M	55.52M	16.02M	138M	20.21M
Unearned Revenue Current, Total	76.51M	-	-	-	-
Other Current Liabilities	160M	244M	286M	307M	284M
Total Current Liabilities	2.43B	3.23B	3.79B	3.71B	3.31B
Long-Term Debt	758M	1.68B	1.99B	1.79B	1.34B
Long-Term Leases	229M	218M	448M	413M	354M
Pension & Other Post Retirement Benefits	65.14M	66.99M	59.82M	58.68M	47M
Deferred Tax Liability Non Current	746M	728M	671M	652M	670M
Other Non Current Liabilities	26.83M	24.64M	23.3M	23.44M	22.9M
Total Liabilities	4.25B	5.95B	6.99B	6.65B	5.75B
Common Stock, Total	867M	867M	867M	867M	867M
Additional Paid In Capital	261M	263M	271M	271M	271M
Retained Earnings	2.27B	2.12B	1.74B	1.75B	2.05B
Comprehensive Income and Other	-193M	-307M	51.9M	624M	1.98B
Total Common Equity	3.21B	2.94B	2.93B	3.51B	5.16B
Minority Interest	696M	511M	515M	648M	660M
Total Equity	3.91B	3.45B	3.44B	4.16B	5.82B
Total Liabilities And Equity	8.16B	9.4B	10.43B	10.81B	11.57B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	86.75M	86.75M	86.75M	86.75M	86.75M
ECS Total Common Shares Outstanding	86.75M	86.75M	86.75M	86.75M	86.75M
Book Value / Share	36.99	33.91	33.76	40.51	59.53
Tangible Book Value	3.1B	2.86B	2.89B	3.47B	5.12B
Tangible Book Value Per Share	35.78	33.01	33.27	40.02	59.03
Total Debt	2.4B	4.22B	5.02B	4.84B	4.23B
Net Debt	74.35M	2.18B	3.15B	2.74B	2.62B
Debt Equivalent of Unfunded Proj. Benefit Obligation	65.14M	66.99M	59.82M	58.68M	47M
Debt Equivalent Oper. Leases	115M	157M	211M	141M	171M
Minority Interest, Total (Incl. Fin. Div)	696M	511M	515M	648M	660M
Equity Method Investments, Total	13.49M	171M	155M	132M	155M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	97.76M	97.85M	104M	116M	139M
Inventories - Work In Process, Total	22.75M	6.24M	21.39M	22.63M	42.78M
Inventories - Finished Goods, Total	1.19B	923M	1.14B	957M	851M
Inventories - Others	39.26M	54.63M	34.42M	50.76M	32.09M
Land - (BS)	578M	1.46B	1.17B	1.17B	1.16B
Buildings, Total	1.75B	2.19B	2.24B	2.35B	2.3B
Machinery, Total	918M	965M	993M	1.07B	1.08B
Assets on Operating Lease - Gross	57.22M	57.2M	56.89M	58.09M	58.09M
Assets on Operating Lease - Accumulated Depreciation	-12.44M	-14.29M	-15.85M	-18.11M	-19.84M
Accumulated Allowance for Doubtful Accounts (Supple)	5.76M	3.3M	2.91M	4.44M	24.48M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	199M	120M	-311M	144M	-284M
Depreciation & Amortization - CF	175M	168M	212M	212M	203M
Amortization of Goodwill and Intangible Assets - (CF)	21.98M	22.67M	6.55M	4.11M	3.18M
Depreciation & Amortization, Total	197M	191M	219M	216M	207M
(Gain) Loss From Sale Of Asset	-1.17M	-182M	-72.35M	-234M	4.83M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-6.15M
Asset Writedown & Restructuring Costs	28.33M	10M	35.3M	-	-
(Income) Loss On Equity Investments - (CF)	16.88M	19.14M	30.14M	18.26M	27.29M
Provision and Write-off of Bad Debts	-356K	-2.46M	-396K	1.53M	20.04M
Other Operating Activities, Total	-44.01M	-22.62M	86.01M	133M	162M
Change In Accounts Receivable	140M	-60.86M	-113M	-14.93M	-130M
Change In Inventories	48.57M	210M	-391M	129M	-67K
Change In Accounts Payable	-15.56M	-159M	393M	-202M	-173M
Change in Other Net Operating Assets	40.08M	-46.25M	-94.12M	-69.44M	52.48M
Cash from Operations	609M	77.65M	-219M	121M	-121M
Capital Expenditure	-233M	-1.56B	-639M	-99.4M	-99.06M
Sale of Property, Plant, and Equipment	1.12M	216M	102M	424M	2.9M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Sale (Purchase) of Real Estate properties	-19.62M	-	-	-	-
Sale (Purchase) of Intangible assets	-2.33M	-5.05M	-1.93M	-1.3M	-1.14M
Investment in Marketable and Equity Securities, Total	-123M	-137M	-84.86M	-251M	551M
Other Investing Activities, Total	8.6M	-6.95M	12.48M	-10.51M	11.04M
Cash from Investing	-368M	-1.5B	-612M	62.11M	465M
Short Term Debt Issued, Total	29.55M	826M	141M	133M	-
Long-Term Debt Issued, Total	396M	1.25B	702M	154M	354M
Total Debt Issued	426M	2.08B	843M	287M	354M
Short Term Debt Repaid, Total	-	-	-	-	-212M
Long-Term Debt Repaid, Total	-225M	-275M	-323M	-481M	-737M
Total Debt Repaid	-225M	-275M	-323M	-481M	-949M
Common Dividends Paid	-156M	-130M	-73.74M	-	-86.75M
Common & Preferred Stock Dividends Paid	-156M	-130M	-73.74M	-	-86.75M
Other Financing Activities, Total	179M	-311M	-17.78M	-15.44M	-79.74M
Cash from Financing	223M	1.36B	428M	-210M	-761M
Foreign Exchange Rate Adjustments	-94.25M	-104M	244M	-38.28M	116M
Net Change in Cash	369M	-162M	-158M	-64.9M	-301M
Supplemental Items
Cash Interest Paid	30.24M	37.17M	66.9M	105M	110M
Cash Income Tax Paid (Refund)	121M	60.83M	21.75M	21.75M	151M
Levered Free Cash Flow	297M	-1.46B	-689M	147M	-296M
Unlevered Free Cash Flow	316M	-1.43B	-645M	214M	-229M
Change In Net Working Capital	-279M	-4.65M	130M	-53.96M	331M
Net Debt Issued / Repaid	200M	1.8B	520M	-194M	-594M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	0.92	-0.7	-0.94	0.42	-0.04
Return on Total Capital	1.2	-0.88	-1.16	0.51	-0.04
Return On Equity %	2.77	2.02	-8.57	4.45	-4.63
Return on Common Equity	6.22	3.91	-10.59	4.47	-6.54
Margin Analysis
Gross Profit Margin %	44.99	45.12	42.96	46.76	47.05
SG&A Margin	13.79	40.23	40.64	40.69	41.23
EBITDA Margin %	5.18	1.21	0.6	5.13	3.49
EBITA Margin %	2.59	-1.58	-3.02	1.63	-0.08
EBIT Margin %	2.19	-2.06	-3.16	1.54	-0.15
Income From Continuing Operations Margin %	1.99	1.56	-6.24	3.69	-5.26
Net Income Margin %	3.7	2.52	-6.57	3.13	-6.47
Net Avail. For Common Margin %	3.7	2.52	-6.57	3.13	-6.47
Normalized Net Income Margin	4.6	-0.22	-5.15	-0.26	-3.1
Levered Free Cash Flow Margin	5.52	-30.57	-14.56	3.21	-6.74
Unlevered Free Cash Flow Margin	5.87	-30.07	-13.65	4.65	-5.22
Asset Turnover
Asset Turnover	0.67	0.54	0.48	0.43	0.39
Fixed Assets Turnover	1.88	1.35	1.15	1.15	1.12
Receivables Turnover (Average Receivables)	8.77	8.64	7.22	6.07	5.39
Inventory Turnover (Average Inventory)	2.09	2.15	2.26	1.99	2.1
Short Term Liquidity
Current Ratio	1.78	1.21	1.1	1.14	1.2
Quick Ratio	1.18	0.82	0.69	0.78	0.75
Operating Cash Flow to Current Liabilities	0.25	0.02	-0.06	0.03	-0.04
Days Sales Outstanding (Average Receivables)	41.71	42.27	50.56	60.15	67.94
Days Outstanding Inventory (Average Inventory)	174.74	169.62	161.39	182.96	174.03
Average Days Payable Outstanding	42.19	37.19	44.49	71.84	42.77
Cash Conversion Cycle (Average Days)	174.26	174.7	167.46	171.27	199.2
Long Term Solvency
Total Debt/Equity	61.55	122.25	145.9	116.31	72.61
Total Debt / Total Capital	38.1	55.01	59.33	53.77	42.06
LT Debt/Equity	25.29	54.98	70.82	52.92	29.15
Long-Term Debt / Total Capital	15.66	24.74	28.8	24.47	16.89
Total Liabilities / Total Assets	52.14	63.28	66.98	61.5	49.66
EBIT / Interest Expense	3.89	-2.58	-2.15	0.67	-0.06
EBITDA / Interest Expense	10.4	2.44	0.99	2.7	1.86
(EBITDA - Capex) / Interest Expense	2.7	-38.64	-8.2	1.77	0.94
Total Debt / EBITDA	7.64	45.42	72.72	16.88	21.15
Net Debt / EBITDA	0.24	23.47	45.63	9.55	13.1
Total Debt / (EBITDA - Capex)	29.4	-2.87	-8.81	25.82	41.92
Net Debt / (EBITDA - Capex)	0.91	-1.48	-5.53	14.61	25.96
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.65	-11.45	-0.77	-2.93	-4.37
Gross Profit, 1 Yr. Growth %	-13.95	-11.2	-5.51	5.66	-3.77
EBITDA, 1 Yr. Growth %	-42.43	-79.21	-52.57	3.25K	-34.91
EBITA, 1 Yr. Growth %	-60.92	-154.17	95.83	-152.26	-104.73
EBIT, 1 Yr. Growth %	-65.01	-183.63	56.28	-147.22	-109.51
Earnings From Cont. Operations, 1 Yr. Growth %	-21.86	-30.49	-497.56	-157.31	-236.57
Net Income, 1 Yr. Growth %	-19.53	-39.7	-358.63	-146.31	-297.25
Normalized Net Income, 1 Yr. Growth %	-26.68	-104.23	2.63K	-95.14	1.05K
Diluted EPS Before Extra, 1 Yr. Growth %	-19.37	-39.74	-359.63	-146.31	-297.25
Accounts Receivable, 1 Yr. Growth %	-25.46	10.68	25.94	7.19	8.2
Inventory, 1 Yr. Growth %	-8.68	-19.85	20.56	-12.09	-7.15
Net Property, Plant and Equip., 1 Yr. Growth %	2.36	44.46	-3.87	-0.81	-3.39
Total Assets, 1 Yr. Growth %	3.64	15.24	10.92	3.66	7.02
Tangible Book Value, 1 Yr. Growth %	1.1	-7.75	0.78	20.3	47.48
Common Equity, 1 Yr. Growth %	0.44	-8.32	-0.43	19.99	46.94
Cash From Operations, 1 Yr. Growth %	167.65	-87.24	-381.72	-155.31	-287.27
Capital Expenditures, 1 Yr. Growth %	86.26	571.36	-59.1	-84.45	-0.35
Levered Free Cash Flow, 1 Yr. Growth %	-2.07K	-600.86	-52.67	-120.66	401.1
Unlevered Free Cash Flow, 1 Yr. Growth %	67.85K	-562.64	-54.92	-131.9	-3.28K
Dividend Per Share, 1 Yr. Growth %	-16.67	-43.33	-	-	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-1.15	-11.55	-6.26	-1.85	-3.65
Gross Profit, 2 Yr. CAGR %	-3.11	-12.59	-8.4	-0.08	0.83
EBITDA, 2 Yr. CAGR %	-22.11	-65.42	-67.94	97.68	366.95
EBITA, 2 Yr. CAGR %	-37.47	-54.05	1.3	1.16	-84.28
EBIT, 2 Yr. CAGR %	-42.44	-45.99	12.88	-14.09	-78.81
Earnings From Cont. Operations, 2 Yr. CAGR %	-14.89	-26.3	66.24	50.95	-11.53
Net Income, 2 Yr. CAGR %	-10.12	-30.34	24.88	9.44	-4.42
Normalized Net Income, 2 Yr. CAGR %	-13.32	-82.39	-0.8	15.09	-25.32
Diluted EPS Before Extra, 2 Yr. CAGR %	-10.05	-30.29	25.08	9.66	-4.42
Accounts Receivable, 2 Yr. CAGR %	-17.13	-9.17	18.06	16.19	7.69
Inventory, 2 Yr. CAGR %	10.57	-14.45	-1.7	2.95	-9.65
Net Property, Plant and Equip., 2 Yr. CAGR %	8.81	21.6	17.84	-2.35	-2.11
Total Assets, 2 Yr. CAGR %	6.16	9.29	13.06	7.23	5.32
Tangible Book Value, 2 Yr. CAGR %	-1.45	-3.43	-3.58	10.11	33.2
Common Equity, 2 Yr. CAGR %	-1.14	-4.04	-4.46	9.3	32.78
Cash From Operations, 2 Yr. CAGR %	62.2	-41.56	-40.04	24.82	-25.59
Capital Expenditures, 2 Yr. CAGR %	7.45	253.62	65.7	-74.78	-60.63
Levered Free Cash Flow, 2 Yr. CAGR %	477.05	882.02	53.89	-68.18	-35.56
Unlevered Free Cash Flow, 2 Yr. CAGR %	1.42K	5.45K	44.34	-61.37	-41.51
Dividend Per Share, 2 Yr. CAGR %	-8.71	-31.28	-	8.47	-
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	0.99	-4.71	-8.09	-5.16	-2.7
Gross Profit, 3 Yr. CAGR %	-0.62	-5.89	-10.29	-3.94	-1.33
EBITDA, 3 Yr. CAGR %	-19.34	-49.87	-61.05	-5.38	36.51
EBITA, 3 Yr. CAGR %	-31.66	-40.44	-26.32	-18.75	-63.56
EBIT, 3 Yr. CAGR %	-35.34	-34.87	-23.68	-15.58	-58.75
Earnings From Cont. Operations, 3 Yr. CAGR %	-31.92	-20.44	29.26	16.57	46
Net Income, 3 Yr. CAGR %	-24.26	-21.32	7.86	-10.28	33.19
Normalized Net Income, 3 Yr. CAGR %	-17.77	-68.33	-10.34	-63.7	147.71
Diluted EPS Before Extra, 3 Yr. CAGR %	-24.26	-21.29	8.05	-10.18	33.36
Accounts Receivable, 3 Yr. CAGR %	-8.85	-8.74	1.28	14.32	13.46
Inventory, 3 Yr. CAGR %	5.7	-0.68	-4.09	-5.29	-0.53
Net Property, Plant and Equip., 3 Yr. CAGR %	6.54	19.59	12.44	11.26	-2.7
Total Assets, 3 Yr. CAGR %	7.04	9.11	9.83	9.84	7.16
Tangible Book Value, 3 Yr. CAGR %	-0.84	-3.6	-2.05	3.8	21.38
Common Equity, 3 Yr. CAGR %	-0.61	-3.59	-2.85	3.08	20.63
Cash From Operations, 3 Yr. CAGR %	0.41	-30.5	-1.28	-41.64	15.97
Capital Expenditures, 3 Yr. CAGR %	-14.13	97.91	72.29	-24.7	-60.13
Levered Free Cash Flow, 3 Yr. CAGR %	58.97	446.68	257.26	-20.29	-41.18
Unlevered Free Cash Flow, 3 Yr. CAGR %	55.03	914.68	1.02K	-11.65	-45.71
Dividend Per Share, 3 Yr. CAGR %	-15.66	-22.13	-	-12.64	5.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.87	-1.84	-1.97	-3.58	-6.34
Gross Profit, 5 Yr. CAGR %	2.26	-2.28	-3.81	-3.61	-6
EBITDA, 5 Yr. CAGR %	-5.65	-37	-44.24	-12.49	-20.53
EBITA, 5 Yr. CAGR %	-12.09	-30.8	-20.05	-26.87	-60.29
EBIT, 5 Yr. CAGR %	-14.89	-27	-19.25	-27.61	-54.29
Earnings From Cont. Operations, 5 Yr. CAGR %	-4.69	-27.99	-2.7	2.79	11.07
Net Income, 5 Yr. CAGR %	-2.24	-23.86	-7.49	-10.22	2.77
Normalized Net Income, 5 Yr. CAGR %	1.53	-51.1	-11.38	-48.59	-16.66
Diluted EPS Before Extra, 5 Yr. CAGR %	-2.2	-23.82	-7.43	-10.13	2.88
Accounts Receivable, 5 Yr. CAGR %	-3.97	-4.29	1.09	0.52	3.8
Inventory, 5 Yr. CAGR %	9.72	0.6	2.67	0.76	-6.35
Net Property, Plant and Equip., 5 Yr. CAGR %	10.99	16.59	10.93	10.28	6.38
Total Assets, 5 Yr. CAGR %	8.31	7.71	9.41	8.35	8
Tangible Book Value, 5 Yr. CAGR %	2.06	-1.31	-1.95	1.67	10.77
Common Equity, 5 Yr. CAGR %	2.1	-1.33	-2.17	1.37	10.08
Cash From Operations, 5 Yr. CAGR %	-1.13	-6.94	-18.3	-12.16	-11.84
Capital Expenditures, 5 Yr. CAGR %	0.28	35.48	11.69	-13.19	-4.54
Levered Free Cash Flow, 5 Yr. CAGR %	-5.76	43.14	56.27	75.23	81.32
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.94	43.92	50.08	174.46	245.58
Dividend Per Share, 5 Yr. CAGR %	-3.58	-13.93	-	-11.09	-11.09